We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

KV Enjoined From Making, Shipping Unapproved Drugs

Law360 (March 2, 2009, 12:00 AM EST) -- KV Pharmaceutical Co. has entered into a consent decree with the U.S. Food and Drug Administration that permanently enjoins the company, its subsidiaries Ethex Corp. and Ther-Rx Corp., and its principal officers from making and distributing adulterated and unapproved drugs.

The injunction against St. Louis-based KV and the other defendants aims to prevent them from manufacturing and shipping drugs until the firm obtains FDA approval and will remain in place until the defendants sustain continuous compliance with the FDA's current good manufacturing practice and new drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.